The biocatalyst market has seen considerable growth due to a variety of factors.
• The biocatalyst market has grown strongly in recent years. It will expand from $0.57 billion in 2024 to $0.61 billion in 2025, at a CAGR of 7.6%.
Growth drivers include the demand for sustainable manufacturing, extensive use in pharmaceuticals and food industries, increased research and development activities, rising environmental awareness, technological progress, and regulatory support.
The biocatalyst market is expected to maintain its strong growth trajectory in upcoming years.
• The biocatalyst market is projected to grow to $0.81 billion by 2029, with a CAGR of 7.3%.
Growth drivers include the demand for sustainable manufacturing processes, expanding use in pharmaceuticals and biofuels, new enzyme engineering technologies, green chemistry initiatives, adoption of biocatalysts in agriculture, and an evolving regulatory landscape. Key trends include innovative biocatalyst formulations for niche applications, sustainable manufacturing, expansion in enzymatic processes, synthetic biology techniques, new enzyme immobilization methods, AI integration in enzyme discovery, and biocatalyst-based carbon capture solutions.
A growing preference for natural food products is expected to boost the biocatalyst market. Natural food products, produced without synthetic chemicals or GMOs, are gaining popularity due to increased consumer health consciousness and a demand for food transparency. Biocatalysts, such as enzymes, enhance the production processes of these natural foods. For example, sales of organic products in North America reached $63 billion in 2022, with organic food experiencing a 2% growth, which is driving the biocatalyst market.
The biocatalyst market covered in this report is segmented –
1) By Type: Oxidoreductases, Transferases, Hydrolases, Other Types
2) By Sources: Plants, Animals, Microorganisms
3) By Application: Food And Beverages, Cleaning Agent, Biofuel Production, Agriculture And Feed, Biopharmaceuticals, Other Applications
Subsegments:
1) By Oxidoreductases: Alcohol Dehydrogenases, Glucose Oxidases, Laccases
2) By Transferases: Aminotransferases, Methyltransferases, Acyltransferases
3) By Hydrolases: Proteases, Lipases, Amylases
4) By Other Types: Lyases, Isomerases, Ligases
Key players in the biocatalyst market are prioritizing the development of advanced biocatalysts like nucleases to boost the efficiency of biotechnological processes and reduce manufacturing costs. Nucleases are enzymes that help break down nucleic acids such as DNA and RNA by catalyzing the hydrolysis of their phosphodiester bonds. For example, in March 2023, UK-based Biocatalysts Ltd. introduced Nuclease 46L (N046L), an enzyme designed to degrade nucleic acids from diverse sources. This enzyme provides a cost-effective solution for DNA removal in various biotechnology applications, improving downstream efficiency and ensuring nucleic acid-free food products.
Major companies operating in the biocatalyst market are:
• BASF SE
• F. Hoffmann-La Roche AG
• Evonik Industries AG
• Koninklijke DSM N.V.
• Novozymes A/S
• Chr. Hansen Holding A/S
• Piramal Pharma Solutions
• Ginkgo Bioworks Inc.
• Codexis Inc.
• BBI Solutions
• AB Enzymes GmbH
• BRAIN Biotech AG
• DuPont Industrial Biosciences
• Amano Enzyme Inc.
• Biosynth Carbosynth AG
• BioCat GmbH
• Enzyme Development Corporation
• Prozomix Limited
• evoxx technologies GmbH
• Enzymicals AG
• Dyadic International Inc.
• Advanced Enzyme Technologies Ltd.
• Creative Enzymes
• Direvo Industrial Biotechnology GmbH
North America was the largest region in the biocatalyst market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biocatalyst market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.